WHO informal consultation on medium- and long-term priorities for ARV drug optimization
Moving towards simplification, harmonization and universal access
WHO convened an informal "think tank" meeting, on 29-31 May 2012 in Montreux, Switzerland, bringing together a group of experts to identify and reflect on opportunities and challenges for antiretroviral (ARV) drug optimization for the next 5 years. This report summarizes the main discussions and conclusions arising from the meeting and aims to inform potential directions on future treatment strategies. These conclusions are preliminary and are intended to inform, but not replace, the WHO normative guideline development process, for which systematic reviews, GRADE evidence profiles and programmatic risk-benefit assessments are currently underway to inform the next set of global guidelines that are planned to be released in 2013.